Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Blueprint Medicines Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 280
- −6 vs. Q3 2021
- Shares held
- 59.1M
- −168.8K (−0.3%) vs. Q3 2021
- Total value
- $6.32B
- +$234.6M (+3.9%) vs. Q3 2021
- New holders
- 30
- 98 more added
- Sold out
- 36
- 108 more reduced
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPMC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $129 |
| Q1 2026 | 6 | $38.6K |
| Q4 2025 | 8 | $2.57M |
| Q3 2025 | 12 | $2.58M |
| Q2 2025 | 356 | $8.65B |
| Q1 2025 | 353 | $6.12B |
| Q4 2024 | 346 | $5.86B |
| Q3 2024 | 319 | $6.04B |
| Q2 2024 | 305 | $7.15B |
| Q1 2024 | 282 | $6.25B |
| Q4 2023 | 260 | $5.91B |
| Q3 2023 | 220 | $3.25B |
| Q2 2023 | 222 | $4.03B |
| Q1 2023 | 215 | $2.84B |
| Q4 2022 | 223 | $2.74B |
| Q3 2022 | 240 | $4.15B |
| Q2 2022 | 237 | $3.19B |
| Q1 2022 | 248 | $3.82B |
| Q4 2021 | 280 | $6.32B |
| Q3 2021 | 289 | $6.13B |
| Q2 2021 | 281 | $5.14B |
| Q1 2021 | 264 | $5.69B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Blueprint Medicines Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marathon Capital Management | 0 | $0 | 0.00% | −2,839−100.0% | Sold out |
| Cim Investment Mangement Inc | 0 | $0 | 0.00% | −2,825−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −2,610−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −2,596−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −2,556−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −2,401−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −2,227−100.0% | Sold out |
| Agf Investments Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Twin Tree Management, LP | 0 | $0 | 0.00% | −1,460−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −786−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −551−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −216−100.0% | Sold out |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| First Mercantile Trust Co | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |